Metatron Health

Botanical species · safety record

Sanguisorba officinalis

The EFSA Compendium of Botanicals holds 5 constituent measurements for Sanguisorba officinalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Sanguisorba officinalis L.

5Constituent measurements
0Safety records
5Cited sources
68Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 68 licensed products naming Sanguisorba officinalis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Root
  • Root (carbonized)
  • Root (charred)
  • Root and Rhizome

What the records describe

Constituents measured

  • Neolignans1
  • Sanguiin h-61
  • Saponins1
  • Tannic acid1
  • Tannins1

Plant parts

  • Unspecified3
  • Roots and other underground parts2

Preparations

  • Solvent extraction5

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
NeolignansRoots and other underground partsSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
Sanguiin h-6UnspecifiedSolvent extraction—UnspecifiedNo resolvable identifier
SaponinsUnspecifiedSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Tannic acidRoots and other underground partsSolvent extraction19 PercentUnspecifiedNo resolvable identifier
TanninsUnspecifiedSolvent extraction——No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Cao, Aimin., Zhang, Dongfang., Sha, Ming., Liu, Guifang., Wu, Lin. Isolation, identification, and content determination of saponins from Sanguisorba officinalis. Zhongcaoyao, 2003, p. 397-399.
  2. Hollub, Janos. Investigation of tanning agents of Hungarian origin. Magyar timar, 1937, p. 60-64.
  3. Yu, Qi-nan., Xiong, Yong-ai., Yang, Rong-ping., Zhang, Shuai-jie., Yang, Ming. Determination of four tannins in ethyl acetate fraction from Sanguisorba officinalis by UPLC. Zhongchengyao, 2015, p. 574-577.
  4. Tanaka, T., Zhang, H., Jiang, ZH., Kouno, I. Relationship between hydrophobicity and structure of hydrolyzable tannins, and association of tannins with crude drug constituents in aqueous solution . Chemical & pharmaceutical bulletin, 1997, vol. 45, no. 12, p. 1891-1897.
  5. Hu, Jiang., Shi, Xiao-Dong., Chen, Jian-Gang., Li, Chang-Sheng. Two new rhamnopyranosides of neolignans from Sanguisorba officinalis. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2012, vol. 14, no. 2, p. 171-175. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature

Europe PMC

Every record indexed for this species, resolvable and re-runnable.

All species

Substance index

Search and browse every species this world holds under source and hash.

Before anything else

Safety Centre

Interactions, contraindications and the escalation boundary this world does not cross.

In its own terms

Traditions

How the living traditions approach preparation, use and context.